Blog
Dr Raghav Sundar: The precision oncology wave in Singapore is coming
Public and private sectors in Singapore are harnessing genomic data through technologies such as Artificial Intelligence to advance the field of precision oncology.
Dr Toh Chee Keong: zimberelimab trialled in new combination immunotherapy for PD-L1 positive metastatic non small cell lung cancer
Similar PD-1 inhibitors have been shown to improve the five-year survival rate of patients with advanced non-small cell lung cancer.
Breast cancer rehabilitation: post mastectomy physical therapy and more
Experts including Dr Mothi Babu Ramalingam from Singapore General Hospital weighed in on breast cancer rehabilitation options in Singapore, including TCM.
Prof Pierce Chow: ELEGANCE study explores cutting-edge methods to detect liver cancer early and more accurately
The multi-centre Singapore study offers active surveillance to patients at high risk of developing liver cancer, with the aim of developing more accurate miRNA diagnostics for early HCC.
Dr Choo Su Pin: New study explores treating advanced-stage HCC patients with Toripalimab and Bevacizumab
The therapy being trialled combines Toripalimab, an anti-PD1 immunotherapy drug developed in China, together with Bevacizumab.
Stage 3 breast cancer survivor: mental health support is crucial in recovery
Tech professional Amy Neary drew on emotional support from her family, friends and Singapore’s Breast Cancer Foundation to cope with the rigorous treatments and surgeries, plus the toll they took on her mental well-being.
Oncoshot named winner at Singapore Business Review National Business Awards 2021
Oncoshot was recognised as winner for the Health Products & Services category, for its commitment to elevate cancer treatment through technology.
Dr Tira Tan: HERBAL trial explores improving cancer survivors’ quality of life through TCM
The Phase II, randomised, double-blinded, placebo-controlled trial, which is being conducted at NCCS, evaluates the safety and efficacy of the Xiang Bei Yang Rong Tang decoction in reducing cancer related fatigue.
Dr Choo Su Pin on ongoing Phase III EMERALD-1 study for cancer patients with intermediate stage HCC
The global study explores the efficacy and safety of transarterial chemoembolization (TACE) treatment in combination with durvalumab monotherapy or TACE with durvalumab plus bevacizumab therapy.
Oncoshot in TechNode Global feature on health-tech start-ups driving innovation in the face of Covid-19
The regional media outlet highlighted Oncoshot's contributions in fostering a more collaborative, data-driven cancer clinical trial landscape.
PRECISE CURATE.AI trial: Dr Dean Ho and Dr Raghav Sundar on pilot study exploring guided dosing with XELOX, XELIRI and single agent capecitabine to treat solid tumours
The Phase I and II single-arm pilot study with multiple cohorts of patient populations harnesses AI for personalised guidance of an individual’s dose modulations based only on his/her data. It aims to re-look at the way oncology clinical trials are designed.
How to ensure successful cancer clinical trial enrolment
Tech-powered solutions such as data-driven pre-screening tools can enable more accurate feasibility studies, thus improving cancer clinical trial enrolment rates.
Liver cancer trial: Dr Toh Han Chong on ongoing study using Atezolizumab plus Bevacizumab to lower recurrence risk in patients with hepatocellular carcinoma
He leads a Phase III, randomised, open-label study of Atezolizumab plus Bevacizumab versus active surveillance as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after surgical resection or ablation.
Breast cancer trial: Dr Yap Yoon Sim on why ongoing clinical trial is significant for patients with PIK3CA-mutant, hormone receptor-positive, Her2-negative, locally advanced or metastatic breast cancer
The phase III, randomised, double-blind, placebo-controlled study evaluates the efficacy and safety of GDC-0077 plus palbociclib and fulvestrant versus placebo plus palbociclib and fulvestrant in patients who meet the specific trial criteria.
Oncoshot wins at Technode Global Origin Innovation Awards 2020
Oncoshot won in the Healthtech category of the Startup Awards, which honour regional startups that embody the spirit of innovation and entrepreneurship.
Oncoshot introduces new cancer clinical trial notification service
The free service is designed to help busy oncologists identify promising cancer clinical trials for their patients in an efficient manner.
What are clinical trials and just how important are they in cancer care?
With cancer continuing to be a leading cause of mortality worldwide, cutting-edge cancer clinical trials can help you expand your treatment options.
Breast cancer: know your screening and treatment options
In light of Breast Cancer Awareness month in October, we highlight potentially live-saving detection methods and new therapies - including those you may access through clinical trials.